Back To: Home : Featured Technology : Assay Development

CLICK HERE FOR WHAT'S NEW IN:
 

Multispan and Promega streamlining GPCR screening
February 2008
by David Hutton  |  Email the author
SHARING OPTIONS:

MADISON, Wis.Promega and San Francisco area-based Multispan have agreed to co-develop assay tools for G-protein coupled receptor (GPCR) screening by combining Multispan GPCR cell lines and Promega bioluminescent technologies. The first tools will support cell lines and cAMP-Glo Assay for quantification of signal. Additional tools will be developed for cell-based assay detection. This combination of validated biologic components and a sensitive and dynamic luminescence assay detection technology for high-throughput screening reportedly will provide increased speed and efficiency in GPCR drug screening. "Pre-optimized protocols will reduce assay development times, from months to days, helping deliver better GPCR targeted drugs faster," according to John Watson, marketing director of pharma/biotech at Promega. "Our suite of assay tools can be combined with Multispan's validated GPCR cell lines to provide turnkey solutions for drug discovery scientists."

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.